The Pharmaceutical Market: Taiwan

Date: January 31, 2013
Pages: 108
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P94E591BB31EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Taiwan
OVERVIEW OF THE PHARMACEUTICAL MARKET IN TAIWAN

We continue to view Taiwan as a challenging market for multinationals, mostly on account of the difficult pricing and reimbursement environment, which is due to undergo further changes. Specifically, as part of the Second Generation National Health Insurance (NHI) programme, which becomes effective in 2013, a new reimbursement system is expected to be rolled out in Taiwan. The American Chamber of Commerce in Taipei (AmCham), in its latest White Paper published in 2012, wrote that it hoped that the new system - known as the Drug Reimbursement Item and Payment Scheme (DRIPS) - will not become so complicated as to cause delays in patient access to innovative new drugs.

Headline Expenditure Projections

Pharmaceuticals: TWD135.10bn (US$4.59bn) in 2011 to TWD140.44bn (US$4.71bn) in 2012; +4.2% in local currency terms and +2.6% in US dollar terms. US dollar f orecast back in the positive territory, unlike in Q412, on account of exchange rate fluctuations.

Healthcare: TWD953.29bn (US$32.42bn) in 2011 to TWD1,018bn (US$34.15bn) in 2012; +6.5% in local currency terms and +5.3% in US dollar terms. Local currency f orecast slightly up since Q412 , on account of macroeconomic factors.

Medical devices: TWD52.63bn (US$1.79bn) in 2011 to TWD55.09bn (US$1.85bn) in 2012; +4.7% in local currency terms and +4.3% in US dollar terms. Local currency f orecast slightly up since Q412 , on account of macroeconomic factors.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

      Taiwan Pharmaceuticals And Healthcare Industry SWOT
      Taiwan Political SWOT
      Taiwan Economic SWOT
      Taiwan Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

      Table: Asia Pacific – Regional Pharmaceutical Business Environment Ratings, Q113
  Rewards
  Risks

TAIWAN – MARKET SUMMARY

REGULATORY REGIME

      Table: Medicine Categories In Taiwan
      Table: Examples Of Controlled Drugs In Taiwan
      Recent Regulatory Developments
      Intellectual Property Regime
      Intellectual Property Developments
      Counterfeits
      Pricing Regime
      Reimbursement Regime
      Table: Reimbursement System in Taiwan
      Table: Drug Reimbursement Principles
      Table: BNHI Spending By Type Of Outpatient Claims, As Percentage Of Total
      Recent Reimbursement Regime Developments
      Free Trade Agreements

INDUSTRY DEVELOPMENTS

      Epidemiology
      Non-Communicable Diseases
      Communicable Diseases
      Healthcare System
      Healthcare Insurance
      Healthcare Insurance Reform
      Table: Sources of Financing
      Healthcare Financing
      Table: Taiwan: Insurance Coverage
      Recent Healthcare System Developments
      Traditional Chinese Medicine
      Biotechnology Sector
      Recent Biotechnology Developments
      Vaccines
      Clinical Trials
      Medical Tourism
      Medical Devices

INDUSTRY FORECAST SCENARIO

  Overall Market Forecast
      Table: Pharmaceutical Sales Indicators Historical Data & Forecast
  Healthcare Market Forecast
      Table: Healthcare Expenditure Indicators Historical Data & Forecast
      Table: Healthcare Governmental Indicators Historical Data & Forecast
      Table: Healthcare Private Indicators Historical Data & Forecast
  Key Growth Factors – Macroeconomic
      Table: Taiwan Macro Indicators
  Prescription Drug Market Forecast
      Table: Prescription Drug Sales Indicators Historical Data & Forecast
  Patented Drug Market Forecast
      Table: Top 10 Pharmaceuticals In Taiwan According To BNHI Expenditure During 2008
      Table: Patented Drug Market Indicators Historical Data & Forecast
  Generic Drug Market Forecast
      Table: Generic Drug Sales Indicators Historical Data & Forecast
  OTC Medicine Market Forecast
      Table: OTC Medicine Sales Indicators Historical Data & Forecast
  Pharmaceutical Trade Forecast
      Table: Exports and Imports Indicators Historical Data & Forecast
  Medical Device Market Forecast
      Table: Medical Devices Sales Indicators Historical Data & Forecast
  Other Healthcare Data Forecasts
  Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry
      Table: Western & TCM Manufacturers, 2006-10
      Table: Pharmaceutical Output Value by Type, 2002-10 (US$mn)
      Domestic Pharmaceutical Sector
      Table: Leading Pharmaceutical Companies According To Market Capitalisation On The Taiwan Stock Exchange (TWSE)
      Table: TGPA Members, 2012
      Recent Domestic Company Activities
      Foreign Pharmaceutical Sector
      Table: Corporate Members Of Taiwan’s International Research-Based Pharmaceutical Manufacturers Association (IRPMA), 2012
      Recent Foreign Company Activity
      Pharmaceutical Wholesale
      Table: Western Drug Distributors 2006-10
      Table: Western Drug Distributors by Region, 2008
      Pharmaceutical Retail
      Table: Pharmacies, 2006-10
      Table: Pharmacies By Region, 2008
      Recent Developments in Pharmaceutical Distribution

COMPANY PROFILES

      Leading Domestic Companies
      Yung Shin Pharmaceutical (YSP)
      ScinoPharm Taiwan
      Empax Pharma
      TaiGen
      Leading Multinationals
    Pfizer
    Sanofi
    GlaxoSmithKline
    Novartis
    Merck & Co

COUNTRY SNAPSHOT: TAIWAN DEMOGRAPHIC DATA

    Section 1: Population
    Table: Demographic Indicators, 2000-2030
    Section 2: Labour Market And Spending Power
    Table: Employment Indicators, 2000-2005
    Table: Consumer Expenditure, 2000-2005 (US$)
    Table: Average Annual Manufacturing Wages, 2005-2012

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Business Environment Ratings
    Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
Skip to top


The Pharmaceutical Market: Germany US$ 1,295.00 Jan, 2013 · 112 pages
The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Taiwan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: